Exploring Science Advocacy and Influential Leadership in Neurological Disorders| Dr. Ron Cohen, CEO, Acorda Therapeutics Inc. 00:10:00

Share On Facebook Share On Twitter

They discuss Dr. Cohen's perspectives on science advocacy, health equity, and influential leadership in the context of developing therapies for neurological disorders, such as Parkinson’s disease and migraine, during Brain Awareness Week in March.

Recent Videos